Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-10-064640
Filing Date
2010-12-29
Accepted
2010-12-29 16:35:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a10-24343_1424b5.htm 424B5 388526
2 GRAPHIC g243431bi07i001.jpg GRAPHIC 4393
3 GRAPHIC g243431bi05i001.jpg GRAPHIC 4395
4 GRAPHIC g243431bi01i001.jpg GRAPHIC 4395
  Complete submission text file 0001104659-10-064640.txt   408672
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-166859 | Film No.: 101278662
SIC: 2836 Biological Products, (No Diagnostic Substances)